Sales decline 31.00% to Rs 1459.25 crore
Net profit of Glenmark Pharmaceuticals declined 72.71% to Rs 194.12 crore in the quarter ended December 2017 as against Rs 711.31 crore during the previous quarter ended December 2016.Sales declined 31.00% to Rs 1459.25 crore in the quarter ended December 2017 as against Rs 2114.95 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales1459.252114.95 -31 OPM %18.2839.93 -PBDT257.03901.23 -71 PBT227.48874.89 -74 NP194.12711.31 -73
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)